---
title: Neutropenic Fever and Cancer
authors:
    - Michelle Lin, MD
created: 2011/10/07
updates: 
    - 2017/05/10
categories:
    - Hematology and Oncology
---

# Neutropenic Fever and Cancer

Chemotherapy causes neutropenia in 10-50% of patients with solid tumors and > 80% of patients with hematologic malignancies during chemotherapy cycle

**Fever:** &ge; 38.3 C (101 F) or ≥ 38.0 C (100.4 F) over 1-hour period

**Neutropenia:** Absolute neutrophil count &lt; 500 cells/mm3

## MASCC score

**Multinational Association for Supportive Care in Cancer (MASCC) Score**

| Criteria                                                                                          |                         Points |
| ------------------------------------------------------------------------------------------------- | -----------------------------: |
| Burden of febrile neutropenia                                                                     | 5 (if mild) or 3 (if moderate) |
| No hypotension (SBP ≥ 90 mmHg)                                                                    |                              5 |
| No COPD                                                                                           |                              4 |
| Solid tumor or hematologic malignancy <span class="drug">with</span> no previous fungal infection |                              4 |
| No dehydration requiring parenteral fluids                                                        |                              3 |
| Outpatient status                                                                                 |                              3 |
| Age &lt;60 years                                                                                  |                              2 |

### High Risk Patients (require admission)

- MASCC score &lt;21 **OR**
- Any of clinical findings:
  - Prolonged (>7 days duration) and profound neutropenia (ANC ≤100 cells/mm3)
  - Hypotension
  - Pneumonia
  - New abdominal pain
  - Neurologic changes

### Low Risk Patients (may be eligible for outpatient tx)

- MASCC score &ge;21
- Brief (&le;7 days duration) neutropenic periods and few co-morbidities

## Workup

- CBC, BUN/creatinine, electrolytes, AST/ALT, bilirubin
- Chest xray, if respiratory signs or symptoms
- 2 blood cultures (1 central line lumen if present + 1 peripheral vein, or 2 peripheral veins)

## Antibiotic Treatment

### Monotherapy

- Antipseudomonal beta-lactam (eg. <span class="drug">cefipime</span>, <span class="drug">carbapenem</span>, <span class="drug">pip-tazo</span>)
- <span class="drug">Vancomycin</span> is not always indicated in cancer patients with a neutropenic fever.
- Add **vancomycin** only if suspect catheter-related infection, skin/soft tissue infection, pneumonia, hemodynamic instability, colonization with MRSA/VRE/PCN-resistant _Strep pneumoniae_
- _For penicillin allergy_: <span class="drug">Ciprofloxacin</span> + <span class="drug">clindamycin</span>, or <span class="drug">aztremonam</span> + <span class="drug">vancomycin</span>
- _Oral medication options for outpatient_: <span class="drug">Ciprofloxacin</span> + <span class="drug">amoxicillin-clavulanate</span>

## Central line-associated blood stream infection (CLABSI)

**Remove catheter:** Consider removal if any of following: 

- Caused by _S. aureus_, _P. aeruginosa_, fungi, mycobacteria
- Tunnel infection
- Pocket site infection
- Septic thrombosis
- Endocarditis
- Sepsis with hemodynamic instability
- Bacteremia despite ≥72 hours of antibiotics

**Keep catheter** and treat with antiobitics: If coagulase-negative staph

## References

- Fairefield AG et. al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer. 2010 update by the IDSA. Clinical Infectious Disease 2011; 52 (4): e56-93. [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21205990)]
